Montelukast and budesonide combination for children with chronic cough-variant asthma

This study investigated the effectiveness and safety of montelukast combined budesonide (MCB) treatment for children with chronic cough-variant asthma (CCVA). In total, 82 cases of children with CCVA, aged 4 to 11 years were included in this study. All cases received either MCB or budesonide alone b...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiu-ping, Yang, Lin-dong, Zhou, Jin-fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078752/
https://www.ncbi.nlm.nih.gov/pubmed/30045280
http://dx.doi.org/10.1097/MD.0000000000011557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078752/
https://www.ncbi.nlm.nih.gov/pubmed/30045280
http://dx.doi.org/10.1097/MD.0000000000011557

Ejemplares similares